PD22: Prostate Cancer: Localized: Radiation Therapy

Saturday, May 14, 2022

9:30 AM – 11:30 AM

Location: Room 252

Podium Session Moderator(s)

AS

A. Oliver Sartor, MD

Tulane Medical School
John Davis, Dr.

Professor of Urology
MD Anderson Cancer Center
Mack Roach, III, Mr.

Professor Radiation Oncvology & Urology
UCSF

Presentations:

9:30 AM – 9:40 AM

PD22-01: Oncological Outcomes of Sentinel Lymph Node Procedure-Guided Radiotherapy versus Imaging-Guided Radiotherapy for Clinically Localized Prostate Cancer – a Multicenter, Retrospective, Propensity Score Weighted Comparison
Podium Presenter: Hilda De Barros, MD, MSC – Netherlands Cancer Institute
9:40 AM – 9:50 AM

PD22-02: Restaging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography is Associated with Improved Oncological Outcome in Men who Underwent Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer
Podium Presenter: Dennie Meijer
9:50 AM – 10:00 AM

PD22-03: Urinary Function Following High Dose Intensity Modulated Radiotherapy for Clinically Localized Prostate Cancer
Podium Presenter: Shannon Kate Mcnall, MD,BS
10:00 AM – 10:10 AM

PD22-04: Immediate Radiotherapy versus Observation in Patients with Node-Positive Prostate Cancer after Radical Prostatectomy
Podium Presenter: Boris Gershman, MD
10:10 AM – 10:20 AM

PD22-05: Comparison of Low-Dose-Rate Brachytherapy Versus Radical Prostatectomy in Patients with Intermediate-Risk Prostate Cancer: A Propensity-Matched Multi-Institutional Study
Podium Presenter: Hideyasu Tsumura
10:20 AM – 10:30 AM

PD22-06: Salvage radiotherapy guided by functional imaging for macroscopic local recurrence following radical prostatectomy: a multicentric retrospective study
Podium Presenter: Nicolas Benziane Ouaritini, MD
10:30 AM – 10:40 AM

PD22-07: Baseline Self-Reported Fatigue Predicts Overall Survival After Stereotactic Body Radiation Therapy for Localized Prostate Cancer
Podium Presenter: Rishabh Kumar Simhal, BS
10:40 AM – 10:50 AM

PD22-08: Risk of radiation-induced fistula is low and may be increased in patients with prior pelvic radiation or concurrent chemotherapy: a systematic review and meta-analysis
Podium Presenter: Michael J. Sadighian, MSc
10:50 AM – 11:00 AM

PD22-09: Distinguishing Between Prostate Specific Antigen Bounce and Biochemical Recurrence Following Stereotactic Body Radiotherapy for Prostate Cancer
Podium Presenter: Ashley Monaco, BS
11:00 AM – 11:10 AM

PD22-10: High volume biopsy core involvement predicts for elevated PSA nadir following definitive SBRT in intermediate risk prostate cancer
Podium Presenter: Jonathan Lischalk, MD – New York University
11:10 AM – 11:20 AM

PD22-11: Subclinical Inflammation as a Predictor for Erectile Dysfunction after Brachytherapy for Localized Prostate Cancer
Podium Presenter: Laurianne Rita R. Garabed, MD
11:20 AM – 11:30 AM

PD22-12: Comparative study of RARP and carbon ion radiotherapy sexual functional changes for prostate cancer using the propensity score matching method
Podium Presenter: Yoshiyuki Miyazawa, MD, PHD